Molecular Response To Imatinib Is Dependent On Dose In Cml Patients With Low Oct-1 Influx Activity. Patients With High Activity May Respond Equally Well To Standard Or Increased Dose Imatinib.
BLOOD(2006)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要